Document is current
Any future updates will be listed below
-
Authors
Cox, Zachary L.
Damman, Kevin
Testani, Jeffrey M.
- License Information
-
More Information
Article History
Accepted: 1 April 2025
First Online: 28 April 2025
Competing interests
: Z.L.C. reports grants from AstraZeneca and personal fees from Abiomed, Kestra Medical Technologies, Lexicon Pharmaceuticals, Reprieve Cardiovascular and Vectorious. K.D. reports speaker and consultancy fees to his employer from Abbott, AstraZeneca, Boehringer Ingelheim, Echosense, FIRE1 and Novartis. J.M.T. reports grants and/or personal fees from 3ive Labs, Abbott, AstraZeneca, Bayer, BD, Bristol Myers Squibb, Cardionomic, Corteria, Edwards Lifesciences, FIRE1, Lexicon Pharmaceuticals, Lilly, MagentaMed, Merck, Novartis, Otsuka, Precardia, Regeneron, Relypsa, Reprieve, Sanofi, Sequana Medical, Windtree Therapeutics and W.L. Gore. J.M.T. has a patent relating to the treatment of diuretic resistance issued to Yale University and Corvidia Therapeutics, a patent relating to methods for measuring renalase issued to Yale University, and a patent relating to the treatment of diuretic resistance pending with Reprieve.
